
Benorilate
We are a manufacturer based in China. We specialize in providing high-quality Benorilate for industrial clients across various sectors. Whether you need chemicals consultation or technical support, our team is here to help.
Category:Active Pharmaceutical Ingredients Own Brand:MT /MOQ:100KG /From China/ B2B only.
Introduction
Catalog ID80017970
CAS NO.5003-48-5
Purity 98%
MDL NumberMFCD00864257
Molecular Formula C17H15NO5
Molecular Weight 313.3047
Melting point: 175~181°C
| Category | Details |
|---|---|
| Chemical Properties | Molecular formula: C16H15NO4<br> Molecular weight: 285.30 g/mol<br> Chemical name: 2-Acetoxybenzoic acid p-acetamidophenyl ester |
| Physical Properties | Appearance: White crystalline powder |
| Mechanism of Action | Benorilate is a prodrug that releases both aspirin and paracetamol (acetaminophen) upon metabolism. Aspirin inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis and providing anti-inflammatory, analgesic, and antipyretic effects. Paracetamol acts centrally to reduce pain and fever. |
| Therapeutic Uses | Indications: Used for mild to moderate pain, such as headaches, toothaches, menstrual pain, and musculoskeletal pain.<br> Fever Reduction: Effective in reducing fever.<br> Inflammation: Provides anti-inflammatory effects for conditions like arthritis. |
| Dosage | Adults: 0.5–1.0 g orally, 3–4 times daily.<br> Elderly: Maximum daily dose of 2.6 g. |
| Side Effects | Gastrointestinal disturbances, hypersensitivity reactions, tinnitus, heartburn, drowsiness, dizziness. |
| Contraindications | Aspirin Sensitivity: Not suitable for individuals allergic to aspirin.<br> Bleeding Disorders: Avoid in patients with bleeding disorders.<br> Peptic Ulcer Disease: Contraindicated in patients with active peptic ulcers.<br> Severe Liver or Kidney Impairment: Use with caution in severe liver or kidney impairment. |
| Storage Conditions | Store in a cool, dry place, protect from light and moisture |
Names and Identifiers
| Name | benorilate |
| Synonyms | benoral benortan benorilate Benorylate benorilato fenasparate aspirinacetaminophenester p-acetamidophenylacetylsalicylate 4-acetamidophenyl O-acetylsalicylate 4′-(acetamido)phenyl-2-acetoxybenzoate 2-acetoxy-4′-(acetamino)phenylbenzoate 4-(acetylamino)phenyl 2-(acetyloxy)benzoate |
| CAS | 5003-48-5 |
| EINECS | 225-674-5 |
| InChI | InChI=1/C17H15NO5/c1-11(19)18-13-7-9-14(10-8-13)23-17(21)15-5-3-4-6-16(15)22-12(2)20/h3-10H,1-2H3,(H,18,19) |
5003-48-5 – Physico-chemical Properties
| Molecular Formula | C17H15NO5 |
| Molar Mass | 313.3 |
| Density | 1.2016 (rough estimate) |
| Melting Point | 177-181℃ |
| Boling Point | 453.11°C (rough estimate) |
| Flash Point | 279°C |
| Water Solubility | 20mg/L(21 ºC) |
| Solubility | DMSO (Slightly), Methanol (Slightly) |
| Vapor Presure | 1.23E-11mmHg at 25°C |
| Appearance | Solid |
| Color | White |
| Merck | 14,1045 |
| pKa | 14.17±0.70(Predicted) |
| Storage Condition | Sealed in dry,Room Temperature |
| Refractive Index | 1.4500 (estimate) |
| Physical and Chemical Properties | White crystalline powder. Melting Point 175-176 °c. Soluble in hot alcohol, insoluble in water. |
| Use | Esterification of acetaminophen and aspirin, suitable for rheumatoid arthritis, rheumatoid arthritis, Head Pain, neuralgia, fever, etc |
5003-48-5 – Risk and Safety
| RTECS | VO0720000 |
| Toxicity | LD50 in mice, rats (mg/ml): 2000, ~10000 orally; 1255, 1830 i.p. (Robertson) |
Reference Information
| Pharmacological action and mechanism of action | Benorilate is a neutral compound that binds aspirin and acetaminophen with ester bonds. It has antipyretic and analgesic effects, and has less adverse reactions than aspirin. Patients are easy to tolerate. After oral administration, it is not hydrolyzed in the gastrointestinal tract, absorbed in the intestine and quickly reaches an effective concentration in the blood. The characteristic is that it rarely causes gastrointestinal bleeding. |
| adverse reactions | 1. mild gastrointestinal reactions such as vomiting, constipation, heartburn, etc. have also been reported to cause diarrhea. 2. It can cause rash. 3. still visible drowsiness, dizziness, disorientation and other neurological and mental symptoms. |
| use | this product is the esterification product of aspirin and paracetamol, and is a new anti-inflammatory, antipyretic, analgesic and rheumatic drug. Adverse reactions are smaller than aspirin, and patients are easy to tolerate. After oral administration, it is not hydrolyzed in the gastrointestinal tract, is easily absorbed and quickly reaches an effective concentration in the blood. Mainly used for rheumatoid arthritis, acute and chronic rheumatoid arthritis, rheumatic pain, cold and fever, headache, postoperative pain, neuralgia, etc. Adverse reactions include vomiting, dyspepsia and constipation. Sleepiness, dizziness and disorientation can still be seen. When the dosage is too large, most people may have tinnitus and deafness. Use with caution in patients with liver and kidney function impairment. Aspirin allergy is contraindicated. The oral LD50 was 2000mg/kg for mice and -10000mg/kg for rats. The LD50 was 1255mg/kg for mice and 1830mg/kg for rats. The esterification of acetaminophen and aspirin, suitable for rheumatoid arthritis, rheumatoid arthritis, headache, neuralgia, fever, etc. |
| Production method | Acetylsalicylic acid is acyl chlorinated to generate acetylsalicylchloride, which is then condensed with p-acetamido phenol to obtain benorilate. |
Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
If you're ready to take the next step, Leave your message below and we’ll reply soon. 20+ years of chemical manufacturing & export experience, a partner you can trust.



